First of all, I'd like to thank you very much for your vitally important support for our Society and your great cooperation with the Education Committee. In addition, I send my sincere thanks to Dr David C L Lam, my predecessor as chair of the Committee, for his great job editing the APSR Bulletin for many years. Through his great cooperation, I succeeded his position right after the APSR 2018 annual congress in Taipei.
As you are aware, we're in an era when the world has been changing very rapidly in such a short time. The amount of information has increased exponentially over in the last decade, where changes on the other side of the world can be observed here instantly. Medical advances are no exception. Academic information arrives, though the actual medical practice is highly dependent on the domestic economic situation.
The role of the Education Committee is to cooperate with APSR members, en bloc member societies and multiple Assemblies, and distribute accurate information to the right place. Currently, as information spreads beyond national borders, we want to share information beyond our medical area while correcting the differences in values.
Needless to say, I'll strive to improve the respiratory pathology and medical practice of the Asia-Pacific region. From this point of view, I believe the APSR Bulletin is one of the most important publications to share such valuable information with you.
Finally, on behalf of the Committee, I wish you all a wonderful holiday season and happy and productive 2019. I really look forward to work closely with you, and welcome any news from you.
Enjoy your New Year holiday!
Arata Azuma
Chairperson, APSR Education Committee
Here's the start of an interactive map which we hope will eventually provide a useful resource of data for your research.
apsresp.org/education/asia-pacific-health/map.html
This beta test version needs more data and we'd welcome details of any source of reliable data for adding to the map.
Please send ideas, suggestions, and data sources to APSRinfo@theapsr.org.
The APSR assemblies today are very different from when they were first formed.
They have evolved in both size and function, and it's time to re-assess whether we need more assemblies, or merge some that overlap, to provide better patient care.
Click the signboard to tell us what you think.
This new initiative is due to launched over the next couple of months.
Please contact your Assembly Head with any items or topics of interest relating to your assembly,
As expected, the Taiwan Society of Pulmonary and Critical Care Medicine, ensured the Congress in Taipei was a tremendous success with delegates from over 40 countries across the Asia-Pacific region and beyond.
The president of APSR2018, Dr Chong-Jen Yu, and the president of TSPCCM, Dr Meng-Chih Lin, reported:
Thank you for not only attending the meetings, but also the social events. Each day, we saw you attending scientific programmes, asking questions, interacting with speaker/chairs, visiting exhibition booths, and connecting to each other. we believe the APSR 2018 has successfully fulfilled its duty to serve as an educational and networking platform for all respiratory specialists in the Asia-Pacific region. We're also confident that you must have enjoyed the beauty of Taipei, the delicious food, as well as safe and comfortable atmosphere when strolling in the city.
On behalf of the Local Congress Committee, I would like to express sincerest gratefulness to you. Thank you again and looking forward to an eternal linkage between you and Taiwan PCCM doctors.
Dr Irene Rosellen P Tan, RMT, MD, from the Philippine General Hospital, was the official Congress Correspondent and regularly tweeted and uploaded messages into social media, posting "blow-by-blow updates of the events".
Perhaps unexpectedly, she was able to meet some of the most prominent respirologists from around the world and is shown on the right with the APSR President, Dr Fong. Her report indicates she thoroughly enjoyed the congress and meeting so many interesting people
Hundreds of other photos were taken at the congress and they will appear on the APSR website soon
Thank you for coming, for getting involved, and for sending feedback of how much you enjoyed the Taipei Congress. Thank you especially for the valuable comments on how we can improve things for future congresses.
The next congress will be 14-17 November 2019 in Hanoi, Vietnam; a popular and exotic location for you to broaden your expertise, share research with your peers, and find valuable new contacts from the thousands of other delegates.
The congress website should be online soon, and meanwhile, updates will be posted on the APSR website
After Hanoi the 26th Congress on 15-18 October 2020 will be in Kyoto, Japan, a city chosen for its popularity at the previous congress there in 2006, and on a date when you can enjoy the spectacular autumn colours at that time of year.
And then the 27th Congress on 18-21 November 2021 in Seoul, Republic of Korea, for which the organisers are already considering ideas for the scientific programme.
Great things ahead!
Dr Philip Eng has now completed his two-year term as chair of the Central Congress Committee, a most challenging role tackled most successfully. He has worked tirelessly to ensure the 2017 congress in Sydney and the 2018 congress in Taipei were conducted at the highest-possible standard. Liaising with those two Local Congress Committees, the two congress organising companies and venues in different countries, 16 APSR assemblies, the other major global respiratory societies, major global industry sponsors, and of course the hundreds of speakers and thousands of congress delegates, it is truly amazing that the congresses ran so smoothly!
He has now passed the role to the committee's chair-elect Dr Kazuto Matsunaga who, like Dr Eng, has been actively involved in running the APSR for many years. We are confident that you will thoroughly enjoy and benefit from the congresses ahead.
Dr David Lam has now handed over his position as chair of the Education Committee to the chair-elect, Dr Arata Azuma.
Dr Lam has been on the Education Committee for ten years; the past eight being the committee's chair. During that time, he has increased the membership of the committee and created a strong team. In addition to managing educational projects (most often single-handedly), he has been Editor-in-Chief of Respiratory Updates for the past eight years, and coordinator of this monthly Bulletin, making sure that every issue over the past ten years has been produced and distributed on time. He provided valuable advice in the creation of the Teaching Library and other projects, but has not restricted himself to these in-house activities. For example, he has given advice and support for many workshops such as the 27 ESAPS that have taken place all over the Asia-Pacific region. All this, in addition to is regular work as a practicing physician, researcher, consultant and other important responsibilities.
Dr Azuma is fortunate that the Committee and its activities he inherits are so well established, but he will still need and appreciate your support to continue the work.
We are delighted to launch this new series with a tribute to the late Ann Janet Woolcock, prepared by Dr Sandra Anderson who delivered the Woolcock Memorial Lecture at the APSR 2018 Congress in Taipei.
This series complements our APSR Members' Honour Roll, on which as a member, you are welcome to add your appreciation of your mentor(s) at any time.
I was introduced to Ann in Sydney in 1970 when I was briefly home on a visit. I was living in London at the time studying exercise-induced asthma in the Department of Paediatrics at the Brompton Hospital. Later Ann visited me at the Brompton and we spoke about her early research in lung volumes in asthmatics during an exacerbation. Her findings had influenced me to make the same measurements before and after exercise had provoked an acute attack of asthma.
Ann had received her Bachelor of Medicine degree from the University of Adelaide but the research for her MD degree was carried out at the University of Sydney and the Royal Prince Alfred Hospital (RPAH) with Professor John Read in the Department of Medicine in the mid 1960's. Ann had the opportunity to measure, by helium dilution, the lung volumes of patients hospitalised for asthma. She reported, for the first time, that the obstruction observed in the asthmatics was associated with marked lung hyperinflation with increases in total lung & functional residual capacities. She repeated the lung volume measurements over a number of days and reported resolution of the hyperinflation, after treatment but in the absence of changes in spirometry in some patients. (Woolcock AJ & Read J Lancet 1965;2:(7426):1323-5, & J Am J Med 1966;41(2):259-73). She also showed that this hyperinflation was associated with a loss of lung elastic recoil, another new finding. (Woolcock AJ & Read J Am Rev Respir Dis 1968;98(5)788-94).
After she had finished her MD she travelled to Montreal to work with Dr Peter Macklem at McGill University. She performed some important studies in animals, the end-result of which gave insight into the frequency dependence of compliance. (Woolcock AJ et al J Clin Invest 1969,48(6):1097-106).
In 1977 she wrote an important article on inhaled drugs in the preventions of asthma (Woolcock AJ Am Rev Respir Dis 1977;115(2):191-4). From her studies in New Guinea Ann had become interested in epidemiology particularly in the frequency of asthma in the community. I joined her study on the prevalence of bronchial hyperresponsiveness (BHR) in the Busselton cohort in 1981. This involved the inhalation of histamine in increasing doses from a hand-held nebuliser until the FEV1 had fallen by 20%. This rapid method was very suitable to use for epidemiological studies and had been developed in Ann's lab in Sydney (Yan K, Salome C Woolcock AJ Thorax 1983;38(10):760-5) This method allowed a small group of us to investigate 916 subjects in just 14 days. (Woolcock AJ et al Thorax 1987; 42(5):361-8.)
An important contribution of Ann's was her identification of a plateau in the airway response of normal subjects to increasing doses of bronchoconstricting agents. The last study that we were both involved in was the inhibitory effect of inhaled cortico-steroid therapy treatment on the response to both to inhaled histamine and inhaled mannitol (Leuppi JD et al Am J Res Crit Care Med 2001;163:406-12).
Ann's contribution to respiratory medicine over 35 years was quite extraordinary – but then she was quite an extraordinary lady.
Here's your last chance to apply for two prestigious travel awards:
APSR Travel Award to the ATS International Conference in Dallas, TX, USA, 17–22 May 2019
See apsresp.org/awards/2019/apsr-yi-to-ats.html for details.
At the same conference is a joint one-day session with APSR and ISRD (International Society for Respiratory Diseases), to which all APSR members are cordially invited to attend.
Travel awards are available for Young Investigator speakers at this session and details are at /awards/2019/apsr-yi-to-isrd.html.
For those requiring a visa for the US, please note that processing can take a long time, depending on nationality and location. Contact your nearest US Embassy for details.
Details of several other 2019 awards can be seen at apsresp.org/awards/index.html
As with the rest of Japan, the office in Tokyo was open as usual over the Christmas period, closed for New Year and will reopen on Monday 7 January.
The staff at the APSR Secretariat office wish you a very happy, healthy and peaceful 2019!
The December issue (Vol 10.12) features Tobacco/Smoking Cessation:
EDITORIALS | |
1 | Triaging treatable traits in asthma |
5 | What triggers acute exacerbations of COPD? Why not ask the patient! |
7 | Towards a refined definition of combined pulmonary fibrosis and emphysema |
9 | Predicting response to bronchial thermoplasty in patients with severe uncontrolled asthma: An elusive goal |
11 | Clinical utility of pulmonary function and blood biomarker measurements |
COMMENTARIES | |
13 | Targeting reactive oxygen species for respiratory infection: Fact or fancy? |
15 | Remarkable progress in cystic fibrosis – But why? |
INVITED REVIEW SERIES | |
Molecular Techniques for Respiratory Diseases | |
17 | The contribution of respiratory microbiome analysis to a treatable traits model of care |
19 | Transcriptomics and single-cell RNA-sequencing |
ORIGINAL ARTICLES | |
Asthma and Allergy | |
29 | Treatable traits can be identified in a severe asthma registry and predict future exacerbations |
COPD | |
37 | Towards an assessment of perceived COPD exacerbation triggers: Initial development and validation of a questionnaire |
Interstitial Lung Disease | |
48 | Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis |
Interventional Pulmonology | |
55 | Bronchodilator responsiveness as a predictor of success for bronchial thermoplasty |
Lung Function | |
63 | Decline in lung function is associated with elevated lipoprotein (a) in individuals without clinically apparent disease: A cross-sectional study |
Pleural Disease | |
68 | Risk factors for pleural effusion recurrence in patients with malignancy |
LETTER FROM ASIA-PACIFIC REGION | |
76 | Letter from Vietnam |
CORRIGENDUM | |
83 | This article corrects doi.org/10.1111/resp.12486 |
The following cases have been selected for inclusion in the January 2019 Respirology Case Reports, Volume 07 Issue 1, and the February 2019 Respirology Case Reports, Volume 07 Issue 2
The significance of non-occupational asbestos exposure in women with mesothelioma
Nonhlanhla Tlotleng, Kerry Sidwell Wilson Nisha, Naicker, Coenraad F N Koegelenberg, David Rees, James Ian Phillips
DOI: 10.1002/rcr2.386 In this report we highlight three cases of mesothelioma in women with diverse environmental exposures. |
Evaluation of expiratory capacity with severe asthma following bronchial thermoplasty
Satoru Ishii, Motoyasu Iikura, Yukiko Shimoda, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama
DOI: 10.1002/rcr2.387 Bronchial thermoplasty (BT) is a bronchoscopic treatment for severe asthma using thermal energy to reduce the amount of smooth muscle in the bronchial wall. In the present study, expiratory computed tomography (CT) imaging was performed before and after BT, and changes in expiratory lung capacity were measured. Use of CT for evaluation of expiratory volume may be a method for assessing the effectiveness of BT. |
Transbronchial lung cryobiopsy: a novel confirmatory tool to diagnose asbestos-related pulmonary fibrosis
Marta Zajaczkowska, Anthony Johnson, Luis Gallur, Joo Shin, Christopher Henderson, Jonathan Williamson
DOI: 10.1002/rcr2.380 Transbronchial cryobiopsy appears to be an effective way of obtaining parenchymal lung samples of sufficient size to diagnose asbestosis when clinical uncertainty exists. |
Pleuritis with pleural effusion due to a Bacillus megaterium infection
Ernesto Crisafulli, Ilaria Aredano, Ilaria Valzano, Barbara Burgazzi, Francesco Andrani, Alfredo Chetta
DOI: 10.1002/rcr2.381 We report a case of a hospitalized male for a pleuritis with pleural effusion caused by a Bacillus megaterium infection, a Gram-positive, aerobic, spore forming and rod-shaped bacterium. To our knowledge, our case report is the first evidence of pleuritis due to B. megaterium. In the literature, up to now B. megaterium infection has only been reported to involve eye, skin and brain. |
Aorto-pleural fistula successfully treated by one-lung ventilation and Endobronchial Watanabe Spigots
Takunori Hozumi, Koichiro Kajiura, Kei Nakamura, Haruki Taniguchi, Takao Goto, Michitaka Nasu
DOI: 10.1002/rcr2.382 Aorto-pleural fistula (APF) is a rare, potentially fatal condition that should be immediately treated by an endovascular or surgical approach. In this case, we treated APF by bronchial occlusion with Endobronchial Watanabe Spigots (EWS) after controlling massive bleeding by one-lung ventilation. |
Gastric perforation related to concurrent use of nintedanib and ramucirumab
Saeko Takahashi, Saori Murata, Yudai Yoshino, Yosuke Kobayashi, Morio Nakamura
DOI: 10.1002/rcr2.383 We report the first case of 70-year-old man taking nintedanib for his progressive idiopathic pulmonary fibrosis (IPF) and treated with ramucirumab plus docetaxel as a seventh line therapy for his pulmonary adenocarcinoma. On day15 of chemotherapy treatment cycle2, after taking nintedanib for nine days, he developed gastric perforation. |
Diffuse pulmonary lymphangiomatosis treated with bevacizumab
Ernest Onyeforo, Adrian Barnett, Debbie Zagami, David Deller, Iain Feather
DOI: 10.1002/rcr2.384 Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease caused by uncontrolled lymphatic vessel proliferation resulting in respiratory dysfunction. We believe this is the first case of DPL to report lung function improvement (forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and DLCO) following bevacizumab therapy. |
Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
Daisuke Minami, Hiroe Kayatani, Ken Sato, Keiichi Fujiwara, Takuo Shibayama
DOI: 10.1002/rcr2.388 We present a patient with both allergic and eosinophilic predominant asthma whose asthma symptom control and sinusitis were improved by benralizumab following negative initial results with omalizumab. |
Autoimmune pulmonary alveolar proteinosis presenting peripheral ground-glass opacities
Keishi Sugino, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi
DOI: 10.1002/rcr2.385 Autoimmune pulmonary alveolar proteinosis should be considered in the differential diagnosis of peripheral ground glass opacities. |
Management of malignant carinal involvement using 'side-by-side' method of bilateral self-expandable metallic stents
Takayuki Takeda, Hideki Itano, Ryo Wakasa, Masahiko Saitoh, Sorou Takeda
DOI: 10.1002/rcr2.396 Central airway obstruction (CAO) is critical and life-threatening for cancer patients and is categorized as an oncological emergency that requires urgent intervention. Malignant carinal involvement is considered one of the most difficult situations among CAO, which is usually treated by rigid bronchoscopic intervention under general anaesthesia. The application of 'side-by-side' method of bilateral self-expandable metallic stents has been reported in the management of malignant carinal involvement. This technique is useful in the treatment of patients of poor performance status who would not tolerate general anaesthesia. We retrospectively analysed six patients who were treated by this method in terms of effectiveness, tolerance, and safety of the procedure. |
Coexistent sarcoidosis and lymphangioleiomyomatosis in a patient with cystic lung disease
Sarah Cullivan, Peter De La Harpe Golden, Deirdre Doyle, Kishore Kumar Doddakula, Louise Burke, Desmond Michael Murphy
DOI: 10.1002/rcr2.389 This is an interesting case of coexistent lymphangioleiomyomatosis and pulmonary sarcoidosis in a 45-year-old lady with cystic lung disease. This case highlights important clinical, radiological, and physiological features of both conditions and suggests a potential shared disease mechanism. |
Pleural anthracosis presenting with massive effusion: a rare entity
Rayhan Amiseno, Andrea Yu-Lin Ban, Noraidah Masir, Lizawati Rasul Hamidi, Mohamed Faisal Abdul Hamid
DOI: 10.1002/rcr2.390 This article is about a patient with recurrent admissions for symptomatic pleural effusion. Diffuse hyperpigmentation in both parietal and visceral pleural was visualised, and biopsy demonstrated granuloma with foreign body giant cell (anthracosis). This case highlights the unusual presentation of pleural anthracosis with pleural effusion. |
Porous diaphragm syndrome with recurrent thymoma
Takayo Ota, Yoshikazu Hasegawa, Takafumi Okabe, Akira Okimura, Masahiro Fukuoka
DOI: 10.1002/rcr2.391 Porous diaphragm syndrome is a defect in the diaphragm in which substances pass from the peritoneal to the pleural cavity. Increasing intra-abdominal pressure by ascites and diaphragmatic thinning due to malnutrition by malignancies resulted in the formation of an artificial hole. |
A case of Aspergillus and Nocardia infections after bronchial thermoplasty
Sachi Matsubayashi, Motoyasu Iikura, Takanori Numata, Shinyu Izumi, Haruhito Sugiyama
DOI: 10.1002/rcr2.392 Bronchial thermoplasty (BT) is a bronchoscopic procedure that uses thermal energy to reduce airway smooth muscle mass for treating uncontrolled severe asthma. Bronchial oedema and radiologic changes are generally known as the major complications of BT, but infections have rarely been reported. We describe a case of fungal and bacterial infections that developed after BT. |
A 17-year-old woman with a solitary, mixed squamous cell and glandular papilloma of the bronchus
Takeshi Saraya, Masachika Fujiwara, Hirokazu Kimura, Hidefumi Takei, Hajime Takizawa
Solitary endobronchial papillomas are extremely rare, accounting for only 0.38% of all lung tumours and approximately 7% of all benign epithelial and mesenchymal lung tumours. Here, we present an unexpected case of mixed papilloma in the youngest known patient to date who suffered from chest pain and bloody sputum. |
A symptomatic anterior mediastinal mass with a simultaneous Haemophilus influenzae infection
Hui Zen Hee, Chun-Ku Chen, Yi-Chen Yeh, Chien-Sheng Huang
DOI: 10.1002/rcr2.394 We describe a rare case of unanticipatedly delayed complete resection of a symptomatic teratoma with simultaneous Hemophilus influenza infection, followed by extended rupture into the pleural, lung and bronchus. The clinical presentation, microbiology and radiology features leads to an impression of lung abscess until it was proved otherwise pathologically. |
Lung spindle cell carcinoma harbouring a constitutively active epidermal growth factor receptor mutation
Hiroaki Ikushima, Toshio Sakatani, Yoshio Masuda, Teppei Morikawa, Kazuhiro Usui
DOI: 10.1002/rcr2.395 Lung spindle cell carcinoma is a rare lung tumour with a poor prognosis, and its standard therapy has not been established. Furthermore, little work has been performed on the genetic characteristics of lung spindle cell carcinomas. Here, we report the first case of lung spindle cell carcinoma with an epidermal growth factor receptor mutation. The patient received gefitinib as first-line therapy. |
The spotlight this month is on
Each month we share details of activities of a particular country, region or society.
If you would like the spotlight to be on your country, region or society next month, contact the Bulletin Coordinator or APSR Secretariat.
Summary of activities in 2018 (to 31 October 2018)
Members: | • 1,601 | |
Branch events: | • 44 | |
Attendees at branch events: | • 1,796 | |
Special Interest Groups (SIGs): | • 18 |
Clinical documents: | • 7 in development and 1 published so far | |
Research projects in development: | • Severe Asthma Registry transition to quality clinical registry • Cystic Fibrosis Clinical Trials Network | |
Advocacy: | • Over 15 submissions made so far | |
Awards: | • $996 000 to be dispersed at TSANZRS18 • $1,027,500 total administered funding in 2018 • 15:17 female to male diversity in recipients | |
Education: | • 3 courses with over 200 attendees • 1 Ongoing competency programme • 3 Post Graduate Workshops • 4 Webinars held in 2018 so far | |
Laboratory accreditation: | • 43 Accredited laboratories • 71 Laboratory volunteer assessors |
Venue: | Gold Coast, Australia |
Dates: | 28–30 March 2019 |
Details | www.apcb2019.com |
The Asian Pacific Congress on Bronchology and Interventional Pulmonology (APCB 2019) will take place at the Gold Coast Exhibition and Convention Centre, Australia, 28–30 March 2019, preceding the TSANZSRS Annual Scientific Meeting (30 March – 2 April).
It will attract a distinguished audience comprised of researchers and clinicians in the field of bronchology and interventional pulmonology. The theme is "Case Based Training – Practice and Theory" and it will have a novel design with a hands-on focus; workshops will provide the core part of the Congress.
APCB 2019 promises to offer an exceptional learning opportunity. Case-based learning will take centre stage and local and international faculty have developed a range of interesting and informative cases across 9 key topics. As part of your registration package you will get to choose 4 half-day courses, which will include theory as well as plenty of time to gain hands-on practice in key procedural points relevant to the particular topic.
For more information, or to sign up to receive updates, please go to www.apcb2019.com
We look forward to seeing you on the Gold Coast!
2019 Local Organising Committee
David Fielding
Congress President
Asia Pacific Congress of Bronchology 2019
The 59th Annual Meeting of the Japanese Respiratory Society will be held on 12-14 April 2019 at the Tokyo International Forum.
The Meeting's president will be Prof. Koichiro Tatsumi (Department of Respirology, Chiba University)
Details: www.jrs.or.jp/english/?content_id=27
Respiratory experts in Vietnam are organising an educational symposium: "Cardiopulmonary diagnostics and pediatric pulmonary function testing", endorsed by the APSR as part of the APSR's ESAP programme. It will run on 11–12 January 2019 at the University of Medicine and Pharmacy at Ho Chi Minh City, 17 Hong Bang Street, District 5, Ho Chi Minh City, Vietnam
After this workshop, participants should:
Chair: Ngo Quy Chau
Co-Chair: Le Thi Tuyet Lan
Faculty:
Primary host: Vietnam Respiratory Society
Co-host: Society of Asthma, Allergy and Clinical Immunology of Hochiminh City
On 1 December 2018, the Forum of International Respiratory Societies (FIRS) issued the following press release for World AIDS Day.
Tuberculosis (TB) is the world's leading infectious disease and it accounts for one in three deaths from HIV/AIDS, according to the World Health Organization's (WHO) 2018 report on TB. This is why on World AIDS Day the Forum of International Respiratory Societies (FIRS), of which the APSR is a member, calls on governments, health advocates and non-government organisations to strengthen their response to AIDS and TB.
"AIDS and TB are a deadly combination," said Polly Parsons, MD, President of the American Thoracic Society, a FIRS founding member. "In the developing world, TB is often the first sign a person has HIV. Together, the diseases are far worse than they are alone."
Shortly after AIDS emerged, it fuelled a global resurgence of TB that continues in many low and middle-income countries. According to the Centers for Disease Control and Prevention, HIV infection is the strongest risk factor for progressing from latent to active TB.
WHO estimates that the risk of developing TB is 16-27 times greater in people who are infected with HIV than those who are not. Those infected with HIV are also at greater risk of dying from pneumocystis jiroveci pneumonia (PCP), the most common opportunistic infection of HIV, and from bacterial pneumonia and Kaposi sarcoma.
Since the beginning of the pandemic, AIDS has claimed 35 million lives and left 17 million children without one or both parents. Today nearly 40 million people are living with the disease. Of those, about 25 million live in Africa, according to the WHO.
Effective antiretroviral treatment of the disease has increased to approximately 59 percent of those infected with HIV, but the WHO's recent report on the disease highlights that people living with the disease in countries in the Eastern Mediterranean and in South-East Asia are much less likely to receive antiretroviral therapies.
FIRS believes a global response to HIV/AIDS can be strengthened by:
"The world has made considerable progress in fighting both AIDS and TB through research, education and better treatments, and prevention strategies," Dr. Parsons said. "But to meet the goal the United Nations set to end the AIDS epidemic by 2030, we will have to redouble our global efforts to stop both of these deadly diseases."
The following article has recently been selected from Respirology for its specific educational value. Previous articles on further topics can be seen at apsresp.org/education/articles/index.html
Of special interest to those working in:
* Lung Cancer
* Clinical Respiratory Medicine
Comment by Dr Mark Lavercombe:
Although malignant pleural effusion can be treated with repeated thoracenteses, identification of patients more likely to suffer recurrence of their effusion might lead to earlier definitive intervention. The authors identify several risk factors for recurrence in their cohort, however further study is required to develop a predictive model with external validity.
have kindly sent their donations towards the Society's goals, as outlined at apsresp.org/members/donors.php.
The APSR is profoundly grateful for their generosity.
Congratulations to the following members who have recently become APSR Fellows.
A warm welcome to the following members who have recently joined APSR assemblies. They will undoubtedly enjoy working with and networking with their assembly colleagues.
Assemblies | |
Fenty Anggrainy (Indonesia) | Clinical Allergy & Immunology Tuberculosis Lung Cancer |
Ni Wayan Candrawati (Indonesia) | Critical Care Medicine Bronchoscopy and Interventional Techniques Environmental & Occupational Health and Epidemiology |
Devasahayam J Christopher (India) | Tuberculosis Bronchoscopy and Interventional Techniques Interstitial Lung Disease |
Tsunahiko Hirano (Japan) | COPD Asthma Clinical Respiratory Medicine |
Jasminarti Dwi Kusumawardani Ida Ayu (Indonesia) | Lung Cancer Tuberculosis Clinical Allergy & Immunology |
Muhammad Irfan Ilmi (Indonesia) | Tuberculosis COPD Asthma |
Won-Jung Koh (Republic of Korea) | Tuberculosis Respiratory Infections (non-tuberculous) |
Keiji Oishi (Japan) | COPD Asthma Interstitial Lung Disease |
Irandi Pratomo (Indonesia) | Respiratory Infections (non-tuberculous) Cell and Molecular Biology Clinical Allergy & Immunology |
Jiayuan Sun (China) | Bronchoscopy and Interventional Techniques Critical Care Medicine COPD |
Ye Tun (Myanmar) | Respiratory Structure and Function Tuberculosis Lung Cancer |
Here are the main respiratory events in Asia-Pacific region for the next few months. You can see our full listing on the APSR Calendar.
For more pulmonology events, see apsresp.org/calendar.html
(These events are for information only and APSR endorsement should not be assumed.)
If you have news or announcements that may be of interest to other APSR members, please send details to Bulletin Coordinator Dr Arata Azuma (a-azuma@nms.ac.jp) or APSR Bulletin (bulletin@apsresp.org).